background
human
bocaviru
hbov
recent
discov
parvoviru
associ
mild
sever
lower
respiratori
tract
infect
children
aim
work
determin
human
bocaviru
nasopharyng
aspir
npa
infant
qualit
pcr
determin
acut
human
bocaviru
infect
estim
immunoglobulin
igm
antibodi
serum
enzym
link
immunosorb
assay
result
twenti
two
npa
specimen
patient
respiratori
manifest
posit
hbov
qualit
pcr
elisa
reveal
posit
hbov
igm
antibodi
patient
also
posit
pcr
non
control
posit
techniqu
correl
studi
elisa
pcr
reveal
high
signific
associ
p
x
agreement
also
pcr
detect
npa
sampl
hbov
posit
case
among
patient
identifi
elisa
could
due
high
sensit
efficaci
pcr
elisa
less
sensit
rtpcr
sensit
vs
efficaci
elisa
versu
rtpcr
conclus
hbov
infect
could
diagnos
npa
children
convent
pcr
rapid
sensit
techniqu
elisa
reliabl
serolog
analysi
diagnosi
acut
hbov
infect
estim
igm
antibodi
serum
alland
et
al
report
discoveri
previous
undescrib
human
parvoviru
respiratori
secret
children
respiratori
tract
diseas
sweden
phylogenet
analysi
show
viru
belong
genu
bocaviru
subfamili
parvovirina
famili
parvovirida
close
relat
bovin
parvoviru
bp
minut
viru
canin
mvc
viru
thu
name
human
bocaviru
hbov
human
bocavirus
hbov
contain
open
read
frame
orf
encod
nonstructur
protein
two
capsid
protein
respect
genom
organ
hbov
close
resembl
bovin
parvoviru
type
hbov
report
respiratori
sampl
children
acut
respiratori
tract
diseas
variou
part
world
includ
australia
north
america
europ
asia
africa
suggest
viru
circul
worldwid
pneumonia
acut
bronchiti
bronchiol
main
manifest
hbov
infect
hbov
seem
new
member
communityacquir
respiratori
virus
respiratori
syncyti
viru
adenoviru
influenza
viru
parainfluenza
viru
rhinoviru
caus
common
respiratori
tract
infect
commun
high
copi
number
respiratori
tract
secret
aerosol
contact
transmiss
like
effect
respiratori
virus
hbov
detect
also
nasopharyng
serum
fecal
urin
sampl
obtain
mainli
young
children
around
age
year
predominantli
winter
season
hbov
detect
two
pediatr
patient
organ
transplant
human
immunodefici
virusinfect
pediatr
patient
immunosuppress
adult
patient
diagnosi
hbov
infect
base
pcr
amplif
viral
genom
fragment
present
human
respiratori
serum
stool
urin
sampl
great
number
differ
pcr
techniqu
employ
vari
set
primer
specif
viral
gene
describ
addit
detect
viral
genom
pcr
recent
report
describ
detect
hbovspecif
igg
igmantibodi
hbov
serum
sampl
use
western
blot
immunofluoresc
assay
furthermor
standard
elisa
quantit
determin
hbovspecif
antibodi
establish
aim
work
determin
hbov
respiratori
specimen
npa
infant
qualit
pcr
determin
acut
hbov
infect
estim
igm
antibodi
serum
elisa
cultur
nasopharyng
aspir
patient
posit
patient
cultur
yield
growth
one
pathogen
among
upper
respiratori
tract
normal
flora
gram
posit
cocci
isol
specimen
includ
streptococcu
pneumonia
staphylococcu
aureu
gram
neg
bacilli
detect
specimen
includ
klebsiella
pneumonia
escherichia
coli
pseudomona
aeruginosa
cultur
control
group
show
growth
upper
respiratori
tract
normal
flora
tabl
twenti
two
npa
specimen
patient
posit
hbov
specimen
neg
qualit
pcr
npa
control
group
neg
hbov
also
high
signific
differ
patient
control
group
sinc
p
tabl
eighteen
serum
sampl
patient
respiratori
tract
manifest
posit
hbov
igm
antibodi
elisa
patient
also
posit
pcr
specimen
hbov
neg
elisa
serum
sampl
control
neg
tabl
serum
concentr
igm
antibodi
hbov
detect
significantli
patient
vs
control
p
tabl
show
number
posit
case
differ
diagnost
method
tabl
show
highli
signific
associ
pcr
elisa
techniqu
diagnost
valid
test
includ
sensit
specif
predict
valu
efficaci
hbov
elisa
pcr
calcul
tabl
consid
pcr
refer
method
work
found
elisa
less
sensit
pcr
vs
specif
elisa
higher
pcr
vs
tabl
recent
year
sever
novel
virus
discov
patient
respiratori
infect
use
molecular
biolog
method
novel
virus
includ
human
metapneumoviru
sever
coronavirus
sar
latest
addit
list
human
bocaviru
hbov
attempt
cultur
viru
convent
cell
line
fail
dijkman
et
al
investig
whether
viru
replic
pseudostratifi
human
airway
epithelium
cell
inocul
human
bocavirusposit
nasopharyng
wash
children
viru
replic
monitor
measur
apic
releas
viru
via
realtim
pcr
electron
microscopi
support
ultrastructur
analysi
hbov
viru
like
particl
vlp
use
transmiss
electron
microscop
equip
digit
camera
work
npa
specimen
patient
posit
hbov
high
signific
differ
patient
control
group
p
pcr
detect
four
hbov
posit
case
neg
elisa
could
explain
high
sensit
pcr
elisa
sinc
vs
respect
weissbrich
et
al
found
hbov
dna
npa
sampl
obtain
hospit
infant
children
febril
respiratori
tract
diseas
year
region
northern
bavaria
germani
nesk
et
al
studi
nasopharyng
aspir
npa
serum
sampl
stool
sampl
children
acut
respiratori
diseas
phylogenet
analysi
gene
sequenc
hbovposit
npa
sampl
qualit
result
realtim
hbov
pcr
good
agreement
convent
hbov
pcr
found
npa
posit
hbov
dna
techniqu
et
al
report
uniqu
region
less
immunogen
major
viru
capsid
protein
also
express
hbov
viral
like
particl
vlp
insect
cell
use
igm
igg
elisa
superior
immunoblot
diagnost
perform
present
studi
serum
sampl
patient
respiratori
tract
manifest
posit
hbov
igm
antibodi
elisa
signific
differ
patient
control
group
p
mean
serum
concentr
igm
antibodi
hbov
two
group
vs
also
highli
signific
associ
pcr
elisa
techniqu
p
agreement
et
al
diagnos
acut
primari
hbov
infect
children
expiratori
wheez
lindner
et
al
detect
igm
hbov
elisa
sera
sampl
obtain
hbov
dnaposit
children
infant
infect
respiratori
tract
present
studi
sensit
specif
posit
predict
valu
efficaci
elisa
respect
lindner
et
al
report
diagnost
sensit
specif
antibodi
elisa
high
respect
posit
predict
valu
use
elisa
among
wheez
children
hbov
infect
could
diagnos
npa
convent
pcr
rapid
sensit
techniqu
elisa
reliabl
serolog
analysi
diagnosi
acut
hbov
infect
estim
igm
antibodi
serum
present
case
control
studi
conduct
patient
age
year
male
femal
mean
sd
age
attend
pediatr
outpati
clinic
sham
univers
hospit
cairo
egypt
period
septemb
may
patient
suffer
lower
respiratori
tract
infect
togeth
upper
respiratori
tract
manifest
cough
run
nose
fever
addit
appar
healthi
children
male
femal
match
age
patient
control
group
patient
subject
follow
written
consent
full
histori
take
thorough
clinic
examin
complet
blood
pictur
chest
plain
xray
nasopharyng
aspir
npa
sampl
collect
patient
control
group
subject
microbiolog
examin
qualit
polymeras
chain
reaction
pcr
detect
hbov
serum
sampl
collect
patient
control
group
detect
hbovigm
antibodi
elisa
nasopharyng
aspir
collect
patient
control
group
accord
svensson
et
al
steril
normal
salin
solut
instil
one
nostril
occlud
nostril
use
steril
blunttip
dispos
syring
patient
instruct
forcibl
exhal
lavag
side
steril
specimen
cup
sequenc
repeat
side
nose
npa
specimen
examin
microbiolog
immedi
part
specimen
store
aliquot
pcr
two
ml
blood
sampl
patient
control
collect
vacutain
centrifug
serum
separ
store
hbovigm
antibodi
elisa
done
gram
stain
smear
detect
pu
cell
microorgan
quantit
cultur
npa
specimen
patient
control
done
undilut
tenfold
serial
dilut
inocul
calibr
loop
chocol
agar
blood
agar
macconkey
agar
plate
night
incub
appropri
condit
quantit
npa
cultur
consid
posit
growth
cfuml
observ
dna
extract
npa
sampl
use
high
pure
viral
nucleic
acid
kit
roch
mannheim
germani
accord
instruct
manufactur
amplif
hbov
dna
perform
use
elut
volum
primer
describ
alland
et
al
tabl
amplif
pcr
product
visual
stain
ethidium
bromid
agaros
gel
pcr
reaction
consid
posit
band
expect
size
base
pair
visibl
plasmid
contain
pcr
product
clone
vector
pcr
invitrogen
use
posit
control
hbovigm
antibodi
determin
commerci
avail
immunoglobulin
igm
enzymelink
immunosorb
assay
suppli
dako
glostrup
denmark
quantit
determin
igm
antibodi
hbov
serum
briefli
serum
sampl
dilut
phosphat
buffer
salin
pb
tween
pbst
appli
duplic
well
plate
coat
goat
antihuman
igm
min
room
temperatur
rins
time
pbst
biotinyl
hbov
viral
like
particl
vlp
appli
concentr
ngwell
incub
min
bound
antigen
visual
use
horseradish
peroxidaseconjug
streptavidin
pbst
plu
bovin
serum
albumin
min
follow
ophenylenediamin
dihydrochlorid
h
min
reaction
stop
min
h
absorb
nm
record
cut
absorb
neg
posit
igm
elisa
result
respect
